Work Files Saved Searches
   My Account                                                  Search:   Quick/Number   Boolean   Advanced   Derwent    Help   


 The Delphion Integrated View

  Buy Now:   Buy PDF- 29pp  PDF  |   File History  |   Other choices   
  Tools:  Citation Link  |  Add to Work File:    
  View:  Expand Details   |  INPADOC   |  Jump to: 
  Go to:  Derwent  
 Email this to a friend  Email this to a friend 
       
Title: US5728815: Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
[ Derwent Title ]


Country: US United States of America

View Images High
Resolution

 Low
 Resolution

 
29 pages

 
Inventor: Chung, Leland W. K.; Houston, TX
Chan, James; Sugarland, TX
Logothetis, Christopher; Houston, TX
Hsieh, Jer-Tsong; Sugarland, TX

Assignee: Board of Regents, The University of Texas System, Austin, TX
other patents from UNIVERSITY OF TEXAS (600015) (approx. 1,442)
 News, Profiles, Stocks and More about this company

Published / Filed: 1998-03-17 / 1994-01-07

Application Number: US1994000179569

IPC Code: Advanced: C07K 14/475; C07K 14/51; C07K 16/22; A61K 38/00;
Core: C07K 14/435; C07K 16/18; more...
IPC-7: C07K 14/475;

ECLA Code: C07K14/475; C07K14/51; C07K16/22;

U.S. Class: Current: 530/399; 530/350; 530/412;
Original: 530/399; 530/350; 530/412; 514/002;

Field of Search: 530/350,399,412 435/240.1 514/002

Government Interest:     The government may own rights in the present invention pursuant to NCI grant number IR01-CA-56307-01.

Priority Number:
1994-01-07  US1994000179569

Abstract: The role for a substantially purified human growth factor preparation is shown to contain a distinct polypeptide with apparent Mr on SDS/PAGE of about 220 kD, and to be distinct from bFGF, with a most active fraction at about 220 kD. A human growth factor polypeptide of 157 kD was identified, in human bone marrow aspirates and from bone stromal cells, by immunoblotting with the mAb MS 329, and by affinity isolation using a MS 329 antibody column. A PSA stimulating autocrine factor, PSAF, that is precipitable in ammonium sulfate at between 60-80% saturation is able to induce PSA expression and secretion, and serves as an indicator of androgen independent prostate cell growth.

Attorney, Agent or Firm: Arnold, White & Durkee ;

Primary / Asst. Examiners: Jagannathan, Vasu S.; Cochran Carlson, K.

Maintenance Status: E1 Expired  Check current status
CC Certificate of Correction issued

INPADOC Legal Status: Show legal status actions          Buy Now: Family Legal Status Report

       
Related Applications:
Application Number Filed Patent Pub. Date  Title
US1992000859228 1992-03-30       


       
Parent Case:

BACKGROUND OF THE INVENTION
    The present application is a continuation-in-part of U.S. patent application Ser. No. 07/859,228 filed Mar. 30, 1992, now abandoned, the entire text of which is herein incorporated by reference without disclaimer.

Designated Country: AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE  AU CA EP JP 

Family: Show 7 known family members

First Claim:
Show all 15 claims
What is claimed is:     1. An isolated human prostate cell growth factor which stimulates prostate cell growth, the factor being obtained by a process that comprises the steps of:
  • (a) culturing human bone stromal cells in serum-conditioned media to produce conditioned media;
  • (b) passing said conditioned media over a heparin-affinity column in a low salt-containing buffer to bind the growth factor to the column;
  • (c) washing the column to remove one or more contaminants;
  • (d) eluting bound growth factor from the column with a high salt buffer;
  • (e) fractionating according to size; and
  • (f) further purifying by subjecting said factor to non-reducing SDS-PAGE gel electrophoresis, and electroeluting the protein band having an apparent molecular weight of about 220 kD in said SDS-PAGE gel; and
  • wherein said protein stimulates prostate cell growth.


Background / Summary: Show background / summary

Drawing Descriptions: Show drawing descriptions

Description: Show description

Forward References: Show 5 U.S. patent(s) that reference this one

       
U.S. References: Go to Result Set: All U.S. references   |  Forward references (5)   |   Backward references (0)   |   Citation Link

       
Foreign References: None

Other Abstract Info: CHEMABS 123(15)196045U CHEMABS 128(19)226688D CHEMABS 127(25)342252K CHEMABS 128(19)226688D DERABS C1995-263651 DERABS C1997-525742

Other References:
  • Scopes 1982 Protein Purification -- Principles and Practice Springer-Verlag NY Section 4.5.
  • Hauschka et al. 1986. J. Biol. Chem. 261:12665-12674 Li, et al. 1993. J. Urol. 149 (4 Supple) 481A.
  • M. Chackal-Roy and B.R. Zetter, Faseb Journal, 4(7): A1989, 1990, Abstract No. 1723.
  • M. Chackal-Roy et al., "Stimulation of Human Prostatic Carcinoma Cell Growth by Factors Present in Human Bone Marrow," The American Society for Clinical Investigation, Inc., 84:43-50, 1989. (8 pages) Cited by 5 patents
  • Leland, W.K. Chung, "Fibroblasts Are Critical Determinants in Prostatic Cancer Growth and Dissemination," Cancer and Metastasis Reviews, 10:263-274, 1991. (12 pages) Cited by 2 patents [ISI abstract]
  • Leland, W.K. Chung et al., "Reciprocal Mesenchymal-Epithelial Interaction Affecting Prostate Tumor Growth an Hormonal Responsiveness," Cancer Surveys, 11:91-121, 1991. (31 pages) Cited by 2 patents [ISI abstract]
  • Martin Gleave et al., "Acceleration of Human Prostate Cancer Growth in Vivo by Factors Produced by Prostate and Bond Fibroblasts," Cancer Research, 51:3753-3761, 1991. (9 pages) Cited by 6 patents [ISI abstract]
  • Martin Gleave et al., Journal of Urology, 145 (4 Suppl.), 213A, 1991, Abstract No. 1.
  • M.E. Gleave et al., "Prostate and Bone Fibroblasts Induce Human Prostate Cancer Growth in Vivo: Implications for Bidirectional Tumor-Stromal Cell Interaction in Prostate Carcinoma Growth and Metastasis," Journal of Urology, 147:1151-1159, 1992. (9 pages) Cited by 2 patents [ISI abstract]
  • Martin E. Gleave et al., "Serum Prostate Specific Antigen Levels in Mice Bearing Human Prostate LNCaP Tumors Are Determined by Tumor, Volume and Endocrine and Growth Factors," Cancer Research, 52:1598-1605, 1992. (8 pages) Cited by 9 patents [ISI abstract]
  • Zetter, Bruce R. et al., "Selective Stimulation of Prostatic Carcinoma Cell Proliferation by Transferrin," Proceedings of the National Academy of Science, 89:6197-6201, 1992. (5 pages) Cited by 11 patents [ISI abstract]
  • Bruce Alberts et al., "Molecular Biology of The Cell," 2d ed. Ch. 12:682-683.
  • "Treatment of Metastatic Disease," Urologic Cancer, 12:6-7, 1993.
  • Leland W.K. Chung et al., "Human Prostate Cancer Model: Roles of Growth Factors and Extracellular Matrices," Journal of Cellular Biochemistry, Supplement 16H:99-105, 1992. (7 pages) Cited by 2 patents [ISI abstract]
  • Jer-Tsong Hsieh et al., "Autocrine Regulation of Prostate-specific Antigen Expression in a Human Prostatic Cancer (LNCaP) Subline1," Cancer Research, 53:2852-2857, 1993. (6 pages) [ISI abstract]
  • Leland, W.K. Chung, "Implications of stromal-epithelial interaction in human prostate cancer growth, progression and differentiation," Cancer Biology, 4:183-192,1993. (10 pages) Cited by 2 patents [ISI abstract]
  • J.T. Hsieh et al., "Characterization of Non-Androgenic Prostate-Specific Autocrine Factor(s) with Stimulatory Effect on PSA Gene Expression in Androgen-Independent Human Prostate Cancer Cells," J. of Urol., 149:222A, 1993.
  • J.T. Hsieh et al., "Detection of a Non-Androgen PSA-Inducing Protein Factor(s) in Bone Marrow Aspirates of Patients with Androgen-Refractory Prostate Tumors: A Potential Prognostic Marker(s) for Disease Progression," J. Urol., 149:257A, 1993.
  • Eamonn Rogers et al., "The Role of PSA in the Treatment of Radiorecurrent Prostatic Adenocarcinoma by Salvage Radical Prostatectomy".


  • Inquire Regarding Licensing

    Powered by Verity


    Plaques from Patent Awards      Gallery of Obscure PatentsNominate this for the Gallery...

    Thomson Reuters Copyright © 1997-2010 Thomson Reuters 
    Subscriptions  |  Web Seminars  |  Privacy  |  Terms & Conditions  |  Site Map  |  Contact Us  |  Help